Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.
ACCESS Newswire (Thu, 27-Aug 5:01 PM ET)
OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission
ACCESS Newswire (Fri, 21-Aug 11:46 AM ET)
ACCESS Newswire (Wed, 19-Aug 3:45 PM ET)
OSR Health Sees Global Shareholder Momentum at Critical Inflection Point
ACCESS Newswire (Wed, 19-Aug 6:30 AM ET)
OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development
ACCESS Newswire (Tue, 11-Aug 8:52 AM ET)
ACCESS Newswire (Fri, 7-Aug 3:00 PM ET)
ACCESS Newswire (Mon, 3-Aug 9:02 AM ET)
OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment
ACCESS Newswire (Fri, 31-Jul 12:00 PM ET)
OSR Health, A Message From the CEO
ACCESS Newswire (Mon, 13-Jul 12:37 PM ET)
ACCESS Newswire (Thu, 2-Jul 1:05 PM ET)
OSR Health Inc is a healthcare holding company focused on biomedical technologies in health and wellness. Through its subsidiaries, the company engages in immuno-oncology, regenerative biologics, and medical device technologies to improve health outcomes across various countries.
Osr Health trades on the stock market under the symbol OSRH.
As of September 4, 2026, OSRH stock price was flat at $0.12 with million shares trading.
OSRH has a beta of 1.57, meaning it tends to be more sensitive to market movements. OSRH has a correlation of 0.02 to the broad based SPY ETF.
OSRH has a market cap of $4.09 million. This is considered a Sub-Micro Cap stock.
Last quarter Osr Health reported $315,669 in Revenue and -$.02 earnings per share. This fell short of revenue expectation by $-462,831 and exceeded earnings estimates by $.26.
The top ETF exchange traded funds that OSRH belongs to (by Net Assets): VXF.
OSRH has underperformed the market in the last year with a price return of -80.3% while the SPY ETF gained +19.8%. OSRH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -72.0% and -57.9%, respectively, while the SPY returned +2.0% and +0.6%, respectively.
OSRH support price is $.10 and resistance is $.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OSRH shares will trade within this expected range on the day.